We examined bcl-2 expression as well as p53 expression and mutation in human uterine smooth muscle tumours to determine the influence of bcl-2 expression on prognosis in patients with uterine leiomyosarcomas. The gene discussed is BCL2; the disease is leiomyosarcoma of the corpus uteri.